1. 1) Murrell DF, Daniel BS, Joly P et al : Definitions and outcome measures for bullous pemphigoid : Recommendations by an international panel of experts. J Am Acad Dermatol, 2012 ; 66 : 479-485.
2. 2) Murrell DF, Marinovic B, Caux F et al : Definitions and outcome measures for mucous membrane pemphigoid : Recommendations of an international panel of experts. J Am Acad Dermatol, 2015 ; 72 : 168-174.
3. 4) Chan LS, Ahmed AR, Anhalt GJ et al : The first international consensus on mucous membrane pemphigoid : definition, di agnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol, 2002 ; 138 : 370-379.
4. 5) Schmidt E, Bröcker EB, Goebeler M : Rituximab in treatment-resistant autoimmune blistering skin disorders. Clin Rev Allergy Immunol, 2008 ; 34 : 56-64.
5. 7) Barbis P, Privat Y : Value of colchicine in treating acquired epidermolysis bullosa. Ann Dermatol Venereol, 1989 ; 116 : 301- 307.